BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3319172)

  • 21. Treatment of intra-abdominal infections is appropriate with single-agent or combination antibiotic therapy.
    Malangoni MA; Condon RE; Spiegel CA
    Surgery; 1985 Oct; 98(4):648-55. PubMed ID: 3901372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiology and antimicrobial therapy of diabetic foot infections.
    Joseph WS; Axler DA
    Clin Podiatr Med Surg; 1990 Jul; 7(3):467-81. PubMed ID: 2205347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
    Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
    Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of single-dose cefotetan and multidose cefoxitin as intravenous prophylaxis in elective, open biliary tract surgery: a multicentre, double-blind, randomized study.
    Lapointe RW; Roy AF; Turgeon PL; Lewis RT; Dagenais MH; Joly JR; Scudamore CH; Roy PD; Conly JM; Syrotuik J
    Can J Surg; 1994 Aug; 37(4):313-8. PubMed ID: 8055389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective, randomized, comparative trials in the therapy for intraabdominal and female genital tract infections.
    Harding GK; Nicolle LE; Haase DA; Aoki FY; Stiver HG; Blanchard RJ; Kirkpatrick JR
    Rev Infect Dis; 1984; 6 Suppl 1():S283-92. PubMed ID: 6326244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of ceftizoxime administered twice daily in hospitalized patients with respiratory tract infections.
    Lentnek A; Wikler M; McDevitt J; Sohn C
    Clin Ther; 1984; 7(1):33-9. PubMed ID: 6097357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative clinical evaluation of ceftizoxime with clindamycin and gentamicin and cefoxitin in the treatment of postcesarean endomyometritis.
    Apuzzio JJ; Ganesh V; Pelosi MA; Landau I; Kaminetzky HA; Kaminski Z; Louria DB
    Surg Gynecol Obstet; 1985 Dec; 161(6):518-22. PubMed ID: 3906971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy.
    Hemsell DL; Cunningham FG; Kappus S; Nobles B
    Obstet Gynecol; 1980 Nov; 56(5):629-34. PubMed ID: 7432735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroperative cefoxitin. A double-blind prospective study in the prevention of wound infections.
    Utley RJ; Macbeth WA
    J R Coll Surg Edinb; 1984 May; 29(3):143-6. PubMed ID: 6379170
    [No Abstract]   [Full Text] [Related]  

  • 30. Outpatient management of uncomplicated lower-extremity infections in diabetic patients.
    Lipsky BA; Pecoraro RE; Larson SA; Hanley ME; Ahroni JH
    Arch Intern Med; 1990 Apr; 150(4):790-7. PubMed ID: 2183732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
    Talan DA; Summanen PH; Finegold SM
    Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefotetan: comparative and noncomparative studies in obstetric and gynecologic infections.
    Knuppel RA; O'Bryan D; Lake M
    South Med J; 1988 Feb; 81(2):185-8. PubMed ID: 3422519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, randomized study of three antimicrobial regimens in the prevention of infections after elective colorectal surgery.
    Jewesson P; Chow A; Wai A; Frighetto L; Nickoloff D; Smith J; Schwartz L; Sleigh K; Danforth D; Pezim M; Stoller J; Stiver G
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):155-65. PubMed ID: 9401808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized comparative trial with ceftizoxime and cefotaxime in urinary tract infections.
    Tripi M; Pavone-Macaluso M; Giammanco A; Carella G
    Int Urol Nephrol; 1985; 17(3):195-202. PubMed ID: 3910604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of ceftizoxime and comparative compounds against Bacteroides fragilis in a mouse model of anaerobic infection.
    Grappel SF; Phillips L; Actor P
    J Antibiot (Tokyo); 1984 Apr; 37(4):384-8. PubMed ID: 6327593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceftizoxime treatment of cutaneous and subcutaneous tissue infections.
    Parish LC; Parks DB; Layne PP; Uri JV
    Clin Ther; 1984; 6(5):613-9. PubMed ID: 6090019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic antibiotics in patients undergoing total vaginal or abdominal hysterectomy.
    Tchabo JG; Cutting ME; Butler C
    Int Surg; 1985; 70(4):349-52. PubMed ID: 3914473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of cefazolin, cefoxitin, and ceftizoxime for surgical prophylaxis in colo-rectal surgery.
    Maki DG; Aughey DR
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():281-7. PubMed ID: 6296021
    [No Abstract]   [Full Text] [Related]  

  • 39. Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
    Moore RD; Smith CR; Holloway JJ; Lietman PS
    Arch Intern Med; 1986 Jun; 146(6):1153-7. PubMed ID: 3087307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cefotaxime treatment of osteomyelitis of the foot in the diabetic].
    Herranz A; Barberán J; Gomis M; Alguacil R; Pastor JM
    An Med Interna; 1991 Jun; 8(6):273-80. PubMed ID: 1888840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.